EDN3 and skin squamous cell carcinoma: The positive percent of EDN3 promoter methylation levels in CIN1, CIN2, CIN3 and CSCC patients were 0 (0/49), 8.16% (8/98), 45.05% (41/91) and 87.50% (56/64).